Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KE.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.56NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JD.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XDTNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JN.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.617.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.109 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.8 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.617.1 (Kappa)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.16 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.99NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.17 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.25.1.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.409NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.83NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.162NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Y.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.154NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.137NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.446NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.76 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.398NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.163NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.3 (Theta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAVNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used